Physician profile
Luke E Buxton
NPI 1548792161
$500.10
in general payments reported to CMS, 2019-2025
13 companies · $57.87 in 2025
The $57.87 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.94 · 2021: $28.59 · 2022: $19.00 · 2023: $288 · 2024: $63.09 · 2025: $57.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $408.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $160.65 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $57.45 | 2019-2024 | Fasenra, Tezspire |
| United Therapeutics Corporation | $54.69 | 2023 | Tyvaso |
| Regeneron Healthcare Solutions, INC. | $40.79 | 2023-2024 | Dupixent |
| Jazz Pharmaceuticals INC. | $38.90 | 2025 | |
| Merck Sharp & Dohme LLC | $24.88 | 2024 | Winrevair |
| Amgen INC. | $23.26 | 2023 | Tezspire |
| Intuitive Surgical, INC. | $19.00 | 2022 | |
| Inspire Medical Systems, INC. | $18.97 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.17 | 2019 | |
| Insmed, INC. | $14.75 | 2023 | Arikayce |
| Cook Medical LLC | $14.67 | 2021 | |
| Glaxosmithkline, LLC. | $13.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Buxton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.